Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.
Divgi CR, Bander NH, Scott AM, O'Donoghue JA, Sgouros G, Welt S, Finn RD, Morrissey F, Capitelli P, Williams JM, Deland D, Nakhre A, Oosterwijk E, Gulec S, Graham MC, Larson SM, Old LJ.
Divgi CR, et al. Among authors: welt s.
Clin Cancer Res. 1998 Nov;4(11):2729-39.
Clin Cancer Res. 1998.
PMID: 9829736
Clinical Trial.